706437002 | Container | Electronic Medication Packaging (EMP) devices are adherence control devices incorporated in the packaging of a prescription drug that, although they have distinguishing characteristics, in general allow the storage of relevant information for the study of patient adherence. Some of these common features are real-time monitoring by recording when the patient triggers an event by obtaining the dose or audio-visual signals as a reminder [1]. It is a type of indirect indicator [2] and objective [3]. The most commonly used EMPs are the Monitors Events Medication Systems "MEMS", which allow certain parameters to be monitored using microchips [4,5]. The most common of these is the pill container that has a microchip in the cap that records the date and time of each opening and closing of the bottle. This allows not only to quantify the compliance with the regime, but also the time pattern that follows. It is an expensive method but applicable to the community pharmacy [4] used by Martins AP et al. [6]. It is necessary to take into account certain aspects that are beyond the control of this type of device, such as whether or not the patient actually takes his medication [5] or whether the patient has transferred the pills to another container or does not carry it with him on certain occasions [7,8]. [1] K.D.Checchi,K. F.Huybrechts, J. Avorn, andA. S.Kesselheim. (2014). Electronic medication packaging devices and medication adherence: a systematic review. The Journal of the American Medical Association, vol. 312, no. 12, pp. 1237–1247. [2] Chamorro, M. A. R., García-Jiménez, E., Amariles, P., & Faus, M. J. (2008). Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica. Aten Primaria, 40(8), 413–417. [3] Nguyen, T. M. U., Caze, A. La, & Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. https://doi.org/10.1111/bcp.12194 [4] Rodríguez Chamorro, M. Á., García-Jiménez, E., Gil, A. B., Chamorro, A. R., Pérez Merino, E. M., Faus Dáder, M. J., & Martínez Martínez, F. (2009). Herramientas para identificar el incumplimiento farmacoterapéutico desde la farmacia comunitaria Tools for the identification by community pharmacies of pharmacotherapeutic non-compliance. Pharmaceutical Care España, 11(4), 183–191. [6] Martins AP, Ferreira AP, Costa FA, Cabrita J. (2006). Cómo medir (o no medir) la adhesión en el tratamiento de erradicaión. Pharm Pract. 4(2): 88-94. [5] Lam, W. Y., & Fresco, P. (2015). Medication Adherence Measures: An Overview. BioMed Research International. e217047. https://doi.org/10.1155/2015/217047 [7] K. C. Farmer. (1999). Methods formeasuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics, vol. 21, no. 6, pp. 1074–1090. [8] E. Diaz, H. B. Levine, M. C. Sullivan et al. (2001). Use of the medication event monitoring system to estimate medication compliance in patients with schizophrenia. Journal of Psychiatry and Neuroscience, vol. 26, no. 4, pp. 325–329.

http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Container

706437002 | Container |

Electronic Medication Packaging (EMP) devices are adherence control devices incorporated in the packaging of a prescription drug that, although they have distinguishing characteristics, in general allow the storage of relevant information for the study of patient adherence. Some of these common features are real-time monitoring by recording when the patient triggers an event by obtaining the dose or audio-visual signals as a reminder [1]. It is a type of indirect indicator [2] and objective [3]. The most commonly used EMPs are the Monitors Events Medication Systems "MEMS", which allow certain parameters to be monitored using microchips [4,5]. The most common of these is the pill container that has a microchip in the cap that records the date and time of each opening and closing of the bottle. This allows not only to quantify the compliance with the regime, but also the time pattern that follows. It is an expensive method but applicable to the community pharmacy [4] used by Martins AP et al. [6]. It is necessary to take into account certain aspects that are beyond the control of this type of device, such as whether or not the patient actually takes his medication [5] or whether the patient has transferred the pills to another container or does not carry it with him on certain occasions [7,8]. [1] K.D.Checchi,K. F.Huybrechts, J. Avorn, andA. S.Kesselheim. (2014). Electronic medication packaging devices and medication adherence: a systematic review. The Journal of the American Medical Association, vol. 312, no. 12, pp. 1237–1247. [2] Chamorro, M. A. R., García-Jiménez, E., Amariles, P., & Faus, M. J. (2008). Revisión de tests de medición del cumplimiento terapéutico utilizados en la práctica clínica. Aten Primaria, 40(8), 413–417. [3] Nguyen, T. M. U., Caze, A. La, & Cottrell, N. (2014). What are validated self-report adherence scales really measuring?: A systematic review. British Journal of Clinical Pharmacology, 77(3), 427–445. https://doi.org/10.1111/bcp.12194 [4] Rodríguez Chamorro, M. Á., García-Jiménez, E., Gil, A. B., Chamorro, A. R., Pérez Merino, E. M., Faus Dáder, M. J., & Martínez Martínez, F. (2009). Herramientas para identificar el incumplimiento farmacoterapéutico desde la farmacia comunitaria Tools for the identification by community pharmacies of pharmacotherapeutic non-compliance. Pharmaceutical Care España, 11(4), 183–191. [6] Martins AP, Ferreira AP, Costa FA, Cabrita J. (2006). Cómo medir (o no medir) la adhesión en el tratamiento de erradicaión. Pharm Pract. 4(2): 88-94. [5] Lam, W. Y., & Fresco, P. (2015). Medication Adherence Measures: An Overview. BioMed Research International. e217047. https://doi.org/10.1155/2015/217047 [7] K. C. Farmer. (1999). Methods formeasuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics, vol. 21, no. 6, pp. 1074–1090. [8] E. Diaz, H. B. Levine, M. C. Sullivan et al. (2001). Use of the medication event monitoring system to estimate medication compliance in patients with schizophrenia. Journal of Psychiatry and Neuroscience, vol. 26, no. 4, pp. 325–329.

Container

Container

706437002

http://www.semanticweb.org/parracarlos/ontologies/2019/3/untitled-ontology-31#Electronic_device